PHARMACOLOGY AND PHYSIOLOGY OF THE SUBSTANTIA NIGRA AND BASAL GANGLIA
PHARMACOLOGY AND PHYSIOLOGY OF THE SUBSTANTIA NIGRA AND BASAL GANGLIA
批准号:
3922484
负责人:
J R WALTERS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Parkinson's disease basal ganglia central nervous system central nervous system disorders centrally acting drug corpus striatum denervation dopamine dopamine receptor drug metabolism evoked potentials experimental brain lesion fluorimetry gamma aminobutyrate glutamate decarboxylase laboratory rat neurochemistry neuromuscular disorder chemotherapy neuropeptides neuropharmacology neurophysiology neurotoxins neurotransmitter biosynthesis neurotransmitter metabolism neurotransmitters nontherapeutic iontophoresis pilocarpine probenecid radioimmunoassay radiotracer substantia nigra synapses
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1) Roles of D-1 and D-2 Dopamine Receptors in Basal Ganglia.
Concurrent D-1 and D-2 receptor stimulation is necessary for full
expression of postsynaptic receptor-mediated effects of dopamine
and dopamine agonists in the basal ganglia. Current results have
indicated the interaction between the two receptor subtypes cannot
be localized to the globus pallidus or the substantia nigra; it
appears to take place in the striatum.
2) D-2 Autoreceptor/ D-2 Postsynaptic receptor Studies. The
therapeutic potential of dopamine autoreceptor-selective drugs is
of current concern. One factor contributing to the apparent
ability of dopamine agonists with limited efficacy to selectively
affect the dopamine autoreceptors is the existence of a greater D-
2 receptor reserve at dopamine autoreceptor sites relative to
postsynaptic dopamine receptor sites. Two dopamine antagonists
reported to selectively affect the autoreceptors do not appear
selective for dopamine autoreceptors in our neurophysiological
investigations. Thus, several factors make it possible for a drug
to selectively affect dopamine autoreceptor-mediated function but
current evidence does not suggest that the two receptors are
structurally different.
3) Consequences of Dopamine Cell Degeneration in the Basal
Ganglia. In an animal model of Parkinsonism, we have found
neurophysiological evidence for functional up-regulation of GABA
receptors in the nigra and down-regulation of these receptors and
opioid receptors in the globus pallidus, correlating with decreased
tonic level of activity in striatal input to the nigra and
increased tonic inhibitory input to the globus pallidus. Support
for the continued loss of dopamine terminals as a factor
contributing to altered I-DOPA thresholds in advanced Parkinsonism
was found in rats with bilateral dopamine cell lesions where I-DOPA
is less effective than in unilaterally lesioned rats, presumably
because of the small contralateral dopaminergic innervation
unaffected by the unilateral lesion.
4) Role of the Pedunculopontine Tegmental Nucleus. A marked
reduction in the number of spontaneously active dopamine cells was
found in rats following kainic acid lesions of the pedunculopontine
tegmental nucleus. Thus, this nucleus appears to exert a very
significant tonic influence on substantia nigra dopamine cell
activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHARMACOLOGY AND PHYSIOLOGY OF THE SUBSTANTIA NIGRA AND BASAL GANGLIA
-
批准号:3968918
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J R WALTERS
-
依托单位:
PHARMACOLOGY AND PHYSIOLOGY OF THE SUBSTANTIA NIGRA AND BASAL GANGLIA
-
批准号:3760219
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J R WALTERS
-
依托单位:
PHARMACOLOGY AND PHYSIOLOGY OF THE SUBSTANTIA NIGRA AND BASAL GANGLIA
-
批准号:5203887
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J R WALTERS
-
依托单位:
PHARMACOLOGY AND PHYSIOLOGY OF THE SUBSTANTIA NIGRA AND BASAL GANGLIA
-
批准号:3860765
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J R WALTERS
-
依托单位:
PHARMACOLOGY AND PHYSIOLOGY OF THE SUBSTANTIA NIGRA AND BASAL GANGLIA
-
批准号:4696817
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J R WALTERS
-
依托单位:
PHARMACOLOGY AND PHYSIOLOGY OF THE SUBSTANTIA NIGRA AND BASAL GANGLIA
-
批准号:3782300
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J R WALTERS
-
依托单位:
PHARMACOLOGY AND PHYSIOLOGY OF THE SUBSTANTIA NIGRA AND BASAL GANGLIA
-
批准号:3881688
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J R WALTERS
-
依托单位:
PHARMACOLOGY AND PHYSIOLOGY OF THE SUBSTANTIA NIGRA AND BASAL GANGLIA
-
批准号:3846165
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J R WALTERS
-
依托单位:
PHARMACOLOGY AND PHYSIOLOGY OF THE SUBSTANTIA NIGRA AND BASAL GANGLIA
-
批准号:6162990
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J R WALTERS
-
依托单位:
海外基金